Maria A. Satolli
Orbassano, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Supervised (Home-Based Exercise) Prehabilitation Program in Pancreatic Cancer Patients Undergoing to Neoadjuvant Chemotherapy: A Pilot Feasibility Study.
Journal: Medical sciences (Basel, Switzerland)
Published: March 19, 2026
Barriers and Priorities for Immunotherapy Implementation in Advanced Gastric Cancer: Findings from a Two-Phase Qualitative Study.
Journal: Journal of gastrointestinal cancer
Published: January 31, 2026
Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance.
Journal: Cancer investigation
Published: November 27, 2024
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.
Journal: Frontiers in immunology
Published: May 03, 2024
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Journal: Targeted oncology
Published: April 02, 2024
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Journal: Clinical and experimental medicine
Published: July 10, 2023
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma.
Journal: Cancer medicine
Published: February 23, 2023
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy.
Journal: Frontiers in oncology
Published: December 21, 2022
Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis.
Journal: Frontiers in oncology
Published: May 04, 2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
Journal: Journal of chemotherapy (Florence, Italy)
Published: February 14, 2022
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis.
Journal: Journal of chemotherapy (Florence, Italy)
Published: July 27, 2021
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 20, 2021
Last Updated: 09/26/2026